WO2000034323A1 - Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof - Google Patents

Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof Download PDF

Info

Publication number
WO2000034323A1
WO2000034323A1 PCT/US1999/029404 US9929404W WO0034323A1 WO 2000034323 A1 WO2000034323 A1 WO 2000034323A1 US 9929404 W US9929404 W US 9929404W WO 0034323 A1 WO0034323 A1 WO 0034323A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
fluorescent protein
isolated
encodes
organism
Prior art date
Application number
PCT/US1999/029404
Other languages
French (fr)
Inventor
Sergey Anatolievich Lukyanoy
Arcady Fedorovich Fradkov
Yulii Aleksandrovich Labas
Mikhail Vladimirovich Matz
Original Assignee
Clontech Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clontech Laboratories, Inc. filed Critical Clontech Laboratories, Inc.
Publication of WO2000034323A1 publication Critical patent/WO2000034323A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)

Definitions

  • This invention relates to the field of molecular biology. More specifically, this invention relates to novel fluorescent proteins , cDNAs encoding the proteins and uses thereof.
  • Fluorescence labeling is a particularly useful tool for marking a protein, cell, or organism of interest.
  • a protein of interest is purified, then covalently conjugated to a fluorophore derivative.
  • the protein-dye complex is then inserted into cells of interest using micropipetting or a method o f reversible permeabilization.
  • the dye attachment and insertion steps make the process laborious and difficult to control.
  • An alternative method of labeling proteins of interest is to concatenate o r fuse the gene expressing the protein of interest to a gene expressing a marker, then express the fusion product.
  • Typical markers for thi s method of protein labeling include _-galactosidase, firefly luciferase and bacterial luciferase. These markers, however, require exogenous substrates or cofactors and are therefore of limited use for in vivo studies .
  • a marker that does not require an exogenous cofactor o r substrate is the green fluorescent protein (GFP) of the jellyfish Aequorea ictoria, a protein with an excitation maximum at 395 nm, a second excitation peak at 475 nm and an emission maximum at 5 1 0 nm.
  • GFP green fluorescent protein
  • GFP is a 238-amino acid protein, with amino acids 65-67 involved in the formation of the chromophore.
  • GFP GFP-binding protein
  • GFP expression in plant cells is discussed by Hu and Cheng in Febs Letters 369 ( 1995 ) , 331-334, while GFP expression in Drosophila embryos is described b y Davis et al. in Dev . Biology 170 (1995), 726-729.
  • GFP tertiary structure resembles a barrel (Orm ⁇ et al., Science 273 (1996), 1392- 1395 ; Yang, et al., Nature Biotechnol. 14 (1996), 1246-1251).
  • the barrel consists of beta sheets in a compact structure, where, in the center, an alpha helix containing the chromophore is shielded by the barrel.
  • the compact structure makes GFP very stable under diverse and/or harsh conditions such a s protease treatment, making GFP an extremely useful reporter in general. However, the stability of GFP makes it sub-optimal for determining short-term or repetitive events.
  • GFP GFP reagents useful and optimized for a variety of research purposes.
  • New versions of GFP have b een developed, such as a "humanized" GFP DNA, the protein product o f which has increased synthesis in mammalian cells (Haas, et al., Current Biology 6 ( 1996), 315-324; Yang, et al., Nucleic Acids Research 24 ( 1996), 4592-4593).
  • One such humanized protein is "enhanced green fluorescent protein” (EGFP).
  • EGFP enhanced green fluorescent protein
  • Other mutations to GFP have resulted i n blue-, cyan- and yellow-green light emitting versions.
  • Novel fluorescent proteins result in possible new colors, or produce pH-dependent fluorescence.
  • Other benefits of novel fluorescent proteins include fluorescence resonance energy transfer (FRET) possibilities based on new spectra and better suitability for larger excitation.
  • FRET fluorescence resonance energy transfer
  • the prior art is deficient in novel fluorescent proteins wherein the DNA coding sequences are known.
  • the present invention fulfills this long-standing need in the art.
  • the present invention is directed to DNA sequences encoding fluorescent proteins selected from the group consisting of: (a) an isolated DNA from an organism from the Class Anthozoa which encodes a fluorescent protein; (b) an isolated DNA which hybridizes t o the isolated DNA of (a) and which encodes a fluorescent protein; and (c) an isolated DNA differing from the isolated DNAs of (a) and (b) in codon sequence due to the degeneracy of the genetic code and th at encodes a fluorescent protein.
  • the DNA is isolated from a non -bioluminescent organism from Class Anthozoa. More preferably, the DNA has the sequence shown in SEQ ID No. 55 and the fluorescent protein has the amino acid sequence shown in SEQ ID No. 56.
  • a vector capable of expressing the DNA of the present invention in a recombinant cell comprising said DNA and regulatory elements necessary for expression of the DNA in the cell.
  • the DNA encodes a fluorescent protein having the amino acid sequence shown in SEQ ID No. 56.
  • a host cell transfected with a vector of the present invention, such that the host cell expresses a fluorescent protein .
  • the cell is selected from the group consisting of bacterial cells, mammalian cells, plant cells, insect cells and yeast cells.
  • a representative example of bacterial cell is an E. coli cell.
  • the present invention is also directed to an isolated an d purified fluorescent protein coded for by DNA selected from the group consisting of: (a) isolated DNA from an organism from Class Anthozoa which encodes a fluorescent protein; (b) isolated DNA which hybridizes to the isolated DNA of (a) and which encodes a fluorescent protein; and (c) isolated DNA differing from the isolated DNAs of (a) and (b) in codon sequence due to the degeneracy of the genetic code, and which encodes a fluorescent protein.
  • the protein has the amino acid sequence shown in SEQ ID No. 56.
  • the present invention is also directed to a DNA sequence encoding a fluorescent protein selected from the group consisting of: (a) an isolated DNA which encodes a fluorescent protein, wherein said DNA is from an organism from Class Anthozoa and wherein said organism does not exhibit bioluminescence; (b) an isolated DNA which hybridizes to isolated DNA of (a) and which encodes a fluorescent protein; and (c) an isolated DNA differing from the isolated DNAs o f (a) and (b) in codon sequence due to degeneracy of the genetic co de and which encodes a fluorescent protein.
  • the organism is from Sub-class Zoantharia, Order Corallimorpharia. More preferably, the organism is from Family Discosomatidae, Genus Discosoma. Even more preferably, the organism is Discosoma sp. "green ". Most particularly, the present invention is drawn to a novel fluorescent protein from Discosoma sp. "green ", dgFP512.
  • the present invention is further directed to an amino acid sequence which can be used as a basis for designing an oligonucleotide probe for identification of a DNA encoding a fluorescent protein by means of hybridizaton, wherein the amino acid sequence is selected from the group consisting of SEQ ID Nos. 3, 5, 8, 11, 12, 14.
  • the amino acid sequence is selected from the group consisting of SEQ ID Nos. 3, 5, 8, 11, 12, 14.
  • such an oligonucleotide has a nucleotide sequence selected from th e group consisting of SEQ ID Nos. 4, 6, 7, 9, 10, 13, 15, 16.
  • Figure 1 shows the modified strategy of 3'-RACE used t o isolate the target fragments. Sequences of the oligonucleotides u s ed are shown in Table 2. Dpi and Dp2 are the degenerate primers used in the first and second PCR, respectively (see Tables 3 and 4 for th e sequences of degenerate primers). In the case of Discosoma sp. "green ", the first degenerate primer used was NGH (SEQ ID No. 4), and the second degenerate primer used was NFP (SEQ ID No. 13) ⁇ Please confirm whether the degenerate primers used for dgFP512 are right. If not, please provide the right primers ⁇
  • Figure 2 shows the excitation and emission spectrum o f the novel fluorescent protein from Discosoma sp. "green ", dgFP512.
  • GFP refers to the basic green fluorescent protein from Aequorea victoria, including prior art versions of GFP engineered to provide greater fluorescence or fluoresce in different colors.
  • sequence of Aequorea victoria GFP SEQ ID No.
  • EGFP refers to mutant variant o f GFP having two amino acid substitutions: F64L and S65T (Heim et al., Nature 373 (1995), 663-664).
  • humanized refers to changes made to the GFP nucleic acid sequence to optimize the codons for expression of the protein in human cells (Yang et al., Nucleic Acids Research 24 (1996), 4592-4593).
  • NFP refers to novel fluorescent protein. Specifically, “NFP” refers to dgFP512 in the present invention.
  • a "vector” is a replicon, such as plasmid, phage or cosmid, to which another DNA segment may be attached so as to bring abou t the replication of the attached segment.
  • a "DNA molecule” refers to the polymeric form o f deoxyribonucleotides (adenine, guanine, thymine, or cytosine) in either single stranded form or a double-stranded helix. This term refers only to the primary and secondary structure of the molecule, and does no t limit it to any particular tertiary forms. Thus, this term includes double-stranded DNA found, inter alia, in linear DNA molecules (e.g. , restriction fragments), viruses, plasmids, and chromosomes.
  • a DNA "coding sequence” is a DNA sequence which is transcribed and translated into a polypeptide in vivo when placed under the control of appropriate regulatory sequences.
  • a coding sequence can include, but is not limited to, prokaryotic sequences, cDNA from eukaryotic mRNA, genomic DNA sequences from eukaryotic (e.g., mammalian) DNA, and synthetic DNA sequences.
  • a polyadenylation signal and transcription termination sequence may be located 3' to the coding sequence.
  • hybridization refers to th e process of association of two nucleic acid strands to form a n antiparallel duplex stabilized by means of hydrogen bonding between residues of the opposite nucleic acid strands.
  • oligonucleotide refers to a short (under 1 00 bases in length) nucleic acid molecule.
  • DNA regulatory sequences are transcriptional and translational control sequences, such as promoters , enhancers, polyadenylation signals, terminators, and the like, th at provide for and/or regulate expression of a coding sequence in a ho s t cell.
  • a “promoter sequence” is a DNA regulatory region capable of binding RNA polymerase in a cell and initiating transcription of a downstream (3' direction) coding sequence.
  • the promoter sequence is bounded at its 3 ' terminus by the transcription initiation site and extends upstream ( 5 ' direction) to include the minimum number of bases or elements necessary to initiate transcription at levels detectable above background.
  • a transcription initiation site within the promoter sequence will be found a transcription initiation site, as well as protein binding domains responsible for the binding of RNA polymerase.
  • Eukaryotic promoters will often, but not always, contain "TATA" boxes and "CAT” boxes .
  • Various promoters, including inducible promoters may be used t o drive the various vectors of the present invention.
  • restriction enzymes refer to bacterial enzymes, each of which c u t double-stranded DNA at or near a specific nucleotide sequence.
  • a cell has been "transformed” or “transfected” by exogenous or heterologous DNA when such DNA has been introduced inside the cell.
  • the transforming DNA may or may not be integrated (covalently linked) into the genome of the cell.
  • the transforming DNA may b e maintained on an episomal element such as a plasmid.
  • a stably transformed cell is one in which th e transforming DNA has become integrated into a chromosome so that it is inherited by daughter cells through chromosome replication.
  • a "clone” is a population o f cells derived from a single cell or common ancestor by mitosis.
  • a "cell line” is a clone of a primary cell that is capable of stable growth in vitro for many generations.
  • heterologous region of the DNA construct is a n identifiable segment of DNA within a larger DNA molecule that is n o t found in association with the larger molecule in nature.
  • the heterologous region encodes a mammalian gene
  • the gene will usually be flanked by DNA that does not flank the mammalian genomic DNA in the genome of the source organism.
  • heterologous DNA includes coding sequence in a construct where portions of genes from two different sources have been brought together so as to produce a fusion protein product. Allelic variations or naturally-occurring mutational events do not give rise to a heterologous region of DNA as defined herein.
  • reporter gene refers to a coding sequence attached to heterologous promoter or enhancer elements an d whose product may be assayed easily and quantifiably when th e construct is introduced into tissues or cells.
  • the amino acids described herein are preferred to be in th e "L" isomeric form.
  • amino acid sequences are given in one-letter code (A: alanine; C: cysteine; D: aspartic acid; E: gluetamic acid; F: phenylalanine; G: glycine; H: histidine; I: isoleucine; K: lysine; L: leucine; M: metionine; N: asparagine; P: proline; Q: gluetamine; R: arginine; S: serine; T: threonine; V: valine; W: tryptophane; Y: tyrosine; X: any residue).
  • NH2 refers to the free amino group present at the amino terminus of a polypeptide.
  • COOH refers to the free carboxy group present at the carboxy terminus of a polypeptide. In keeping with standard polypeptide nomenclature, J Biol. Chem., 243 (1969), 3552- 59 is used.
  • the present invention is directed to an isolated DNA selected from the group consisting of: (a) isolated DNA from a n organism from the Class Anthozoa which encodes a fluorescent protein; (b) isolated DNA which hybridizes to isolated DNA of (a) an d which encodes a fluorescent protein; and (c) isolated DNA differing from the isolated DNAs of (a) and (b) in codon sequence due to th e degeneracy of the genetic code, and which encodes a fluorescent protein.
  • the DNA has the sequence shown in SEQ ID No. 5 5 and the fluorescent protein has the amino acid sequence shown in SEQ ID No. 56.
  • a vector capable of expressing the DNA of the present invention in a recombinant cell comprising said DNA and regulatory elements necessary for expression of the DNA in the cell.
  • the DNA encodes a fluorescent protein having the amino acid sequence shown in SEQ ID No. 56.
  • a host cell transfected with the vector of the present invention, which expresses a fluorescent protein of the present invention.
  • the cell is selected from the group consisting o f bacterial cells, mammalian cells, plant cells, insect cells and yeast cells.
  • a representative example of bacterial cell is an E. coli cell.
  • the present invention is also directed to a DNA sequence encoding a fluorescent protein selected from the group consisting of: (a) an isolated DNA which encodes a fluorescent protein, wherein said DNA is from an organism from Class Anthozoa and wherein said organism does not exhibit bioluminescence; (b) an isolated DNA which hybridizes to isolated DNA of (a) and which encodes a fluorescent protein; and (c) an isolated DNA differing from the isolated DNAs o f
  • the organism is from Sub-class Zoantharia, Order Corallimorpharia. More preferably, the organism is from Family Discosomatidae, Genus Discosoma. Most preferably, the organism is Discosoma sp. "green ".
  • the present invention is also directed to an isolated and purified fluorescent protein coded for by DNA selected from the group consisting of: (a) an isolated protein encoded by a DNA which encodes a fluorescent protein wherein said DNA is from an organism from Class
  • the isolated and purified fluorescent protein is dgFP512.
  • the present invention is further directed to an amino acid sequence which can be used as a basis for designing an oligonucleotide probe for identification of a DNA encoding a fluorescent protein by means of hybridizaton, wherein the amino acid sequence is selected from the group consisting of SEQ ID Nos. 3, 5, 8, 11, 12, 14.
  • the amino acid sequence is selected from the group consisting of SEQ ID Nos. 3, 5, 8, 11, 12, 14.
  • such an oligonucleotide has a nucleotide sequence selected from th e group consisting of SEQ ID Nos. 4, 6, 7, 9, 10, 13, 15, 16 and is used a s a primer in polymerase chain reaction.
  • it can be used a s a probe for hybridization screening of the cloned genomic or cDNA library.
  • Amplified cDNA samples were then prepared a s described in the protocol provided except the two primers used for PCR were the TS primer (5'-AAGCAGTGGTATCAACGCAGAGT, SEQ ID No. 2 ) (Table 2) and the TN3 primer (Table 2), both in 0.1 ⁇ M concentration. Twenty to twenty-five PCR cycles were performed to amplify a cDNA sample. The amplified cDNA was diluted 20-fold in water and 1 ⁇ l o f this dilution was used in subsequent procedures.
  • T7-TN3 5'-GTAATACGACTCACTATAGGGCCGCAGTCGACCG(T) 13
  • T7-TS 5'-GTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT
  • PCR using degenerate primers was performed.
  • Degenerate primers were designed to match the sequence of the mRNAs in regions that were predicted to be the most invariant in the family of fluorescent proteins. Four such stretches were chosen (Table 3) and variants o f degenerate primers were designed. All such primers were directed t o the 3 '-end of mRNA. All oligos were gel-purified before use. Table 2 shows the oligos used in cDNA synthesis and RACE.
  • the modified strategy of 3'-RACE was used to isolate th e target fragments (see Figure 1).
  • the RACE strategy involved two consecutive PCR steps.
  • the first PCR step involved a first degenerate primer (Table 4) and the T7-TN3 primer (SEQ ID No. 17) which has a 3 ' portion identical to the TN3 primer used for cDNA synthesis (for sequence of T7-TN3, Table 2).
  • the reason for substituting the longer T7-TN3 primer in this PCR step was that background amplification which occurred when using the shorter TN3 primer was suppres sed effectively, particularly when the T7-TN3 primer was used at a low concentration (0.1 _M) (Frohman et al., (1998) PNAS USA, 85, 8998 - 9002).
  • the second PCR step involved the TN3 primer (SEQ ID No. 1 , Table 2) and a second degenerate primer (Table 4).
  • NGH GEGa SEQ ID No. 6
  • SEQ ID No. 4 NFP (SEQ ID No. 13) or PVMb (SEQ ID No. 16)
  • Discosoma striata NGH NFP (SEQ ID No. 4) (SEQ ID No. 13)
  • the first PCR reaction was performed as follows: 1 ⁇ l of 20-fold dilution of the amplified cDNA sample was added into the reaction mixture containing IX Advantage KlenTaq Polymerase Mix with provided buffer (CLONTECH), 200 ⁇ M dNTPs, 0.3 ⁇ M of first degenerate primer (Table 4) and 0.1 ⁇ M of T7-TN3 (SEQ ID No. 17) primer in a total volume of 20 ⁇ l.
  • the cycling profile was (Hybaid OmniGene Thermocycler, tube control mode): 1 cycle for 95°C, 10 sec; 55°C, 1 min.; 72°C, 40 sec; 24 cycles for 95°C, 10 sec; 62°C, 30 sec; 72°C, 4 0 sec.
  • the reaction was then diluted 20-fold in water and 1 ⁇ l of this dilution was added to a second PCR reaction, which contained IX Advantage KlenTaq Polymerase Mix with the buffer provided by th e manufacturer (CLONTECH), 200 ⁇ M dNTPs, 0.3 ⁇ M of the s econd degenerate primer (Table 4) and 0.1 ⁇ M of TN3 primer.
  • the cycling profile was (Hybaid OmniGene Thermocycler, tube control mode): 1 cycle for 95°C, 10 sec; 55°C (for GEG/GNG or PVM) or 52°C (for NFP), 1 min.; 72°C, 40 sec; 13 cycles for 95°C, lOsec; 62°C (for GEG/GNG o r PVM) or 58°C (for NFP), 30 sec; 72°C, 40 sec.
  • the product of PCR was cloned into PCR-Script vector (Stratagene) according to th e manufacturer' s protocol.
  • the step-out reaction mixture contained lx Advantage KlenTaq Polymerase Mix using buffer provided by the manufacturer (CLONTECH), 200 ⁇ M dNTPs, 0.2 ⁇ M of the first gene-specific primer (see Table 5), 0.02 ⁇ M of the T7-TS primer (SEQ ID No. 18), 0.1 ⁇ M o f T7 primer (SEQ ID No.
  • the cycling profile was (Hybaid OmniGene Thermocycler, tube control mode): 23 - 27 cycles for 95°C, 10 sec; 60°C, 30 sec; 72°C, 40 sec.
  • the product of amplification was diluted 50-fold in water and one ⁇ l of this dilution was added to the second (nested) PCR.
  • the reaction contained IX Advantage KlenTaq Polymerase Mix with provided buffer (CLONTECH), 200 ⁇ M dNTPs, 0.2 ⁇ M of the second gene-specific primer and 0.1 ⁇ M of TS primer (SEQ ID No.
  • Both primers had 5'-heels coding for a site for a restriction endonuclease; in addition, the upstream primer was designed so as to allow the cloning of the PCR product into the pQE30 vector (Qiagen) in such a way that resulted in the fusion of reading frames of the vector-encoded 6xHis-tag and nFP.
  • the PCR was performed as follows: 1 ⁇ l of the 20-fold dilution of the amplified cDNA sample was added to a mixture containing lx Advantage KlenTaq Polymerase Mix with buffer provided by the manufacturer (CLONTECH), 200 ⁇ M dNTPs, 0.2 ⁇ M of upstream primer and 0.2 ⁇ M of downstream primer, in a final total volume of 20 ⁇ l.
  • the cycling profile was (Hybaid OmniGene Thermocycler, tube control mode): 23-27 cycles for 95°C , 10 sec; 60°C, 30 sec; 72°C, 40 sec.
  • the product of this amplification step was purified by phenol-chlorophorm extraction and ethanol precipitation and then cloned into pQE30 vector using restriction endonucleases corresponding to the primers' sequence according t o standard protocols.
  • All plasmids were amplified in XL-1 blue E. coli and purified by plasmid DNA miniprep kits (CLONTECH).
  • the recombinant clones were selected by colony color, and grown in 3 ml of LB medium (supplemented with 100 ⁇ g/ml of ampicillin) at 37°C overnight. 100 ⁇ l of the overnight culture was transferred into 200 ml of fresh LB medium containing 100 ⁇ g/ml of ampicillin and grown at 37°C, 200 rpm up to OD 600 0.6-0.7. 1 mM IPTG was then added to the culture an d incubation was allowed to proceed at 37°C for another 16 hours.
  • the cells were harvested and recombinant protein, which incorporated 6 x His tags on the N-terminus, was purified using TALONTM metal-affinity resin according to the manufacturer's protocol (CLONTECH).
  • dgFP512 One of the full-length cDNAs encoding fluorescent proteins found is described herein (dgFP512).
  • the nucleic acid sequence an d deduced amino acid sequence are SEQ ID Nos. 55 and 56, respectively.
  • the spectral properties of dgFP512 is listed in Table 7, and the emission and excitation spectra for the dgFP512 is shown in Figure 2.
  • *relative brightness is extinction coefficient multiplied by qu antum yield divided by the same value for A. victoria GFP .

Abstract

The present invention is directed to novel fluorescent proteins from non-bioluminescent organisms from the Class Anthozoa. Also disclosed are cDNAs encoding the fluorescent proteins.

Description

FLUORESCENT PROTEINS FROM NON-BIOLUMINESCENT SPECIES OF CLASS ANTHOZOA, GENES ENCODING SUCH PROTEINS AND
USES THEREOF
Field of the Invention
This invention relates to the field of molecular biology. More specifically, this invention relates to novel fluorescent proteins , cDNAs encoding the proteins and uses thereof.
Description of the Related Art
Fluorescence labeling is a particularly useful tool for marking a protein, cell, or organism of interest. Traditionally, a protein of interest is purified, then covalently conjugated to a fluorophore derivative. For in vivo studies, the protein-dye complex is then inserted into cells of interest using micropipetting or a method o f reversible permeabilization. The dye attachment and insertion steps , however, make the process laborious and difficult to control. An alternative method of labeling proteins of interest is to concatenate o r fuse the gene expressing the protein of interest to a gene expressing a marker, then express the fusion product. Typical markers for thi s method of protein labeling include _-galactosidase, firefly luciferase and bacterial luciferase. These markers, however, require exogenous substrates or cofactors and are therefore of limited use for in vivo studies . A marker that does not require an exogenous cofactor o r substrate is the green fluorescent protein (GFP) of the jellyfish Aequorea ictoria, a protein with an excitation maximum at 395 nm, a second excitation peak at 475 nm and an emission maximum at 5 1 0 nm. GFP is a 238-amino acid protein, with amino acids 65-67 involved in the formation of the chromophore.
Uses of GFP for the study of gene expression and protein localization are discussed in detail by Chalfie et al. in Science 263 ( 1994), 802-805, and Heim et al. in Proc. Nat. Acad. Sci. 91 ( 1994) , 12501 - 12504. Additionally, Rizzuto et al. in Curr. Biology 5 ( 1995 ) , 635-642, discuss the use of wild-type GFP as a tool for visualizing subcellular organelles in cells, while Kaether and Gerdes in Febs Letters 369 ( 1995), 267-271 , report the visualization of protein transport along the secretory pathway using wild-type GFP. The expression of GFP in plant cells is discussed by Hu and Cheng in Febs Letters 369 ( 1995 ) , 331-334, while GFP expression in Drosophila embryos is described b y Davis et al. in Dev . Biology 170 (1995), 726-729.
Crystallographic structures of wild-type GFP and the mutant GFP S65T reveal that the GFP tertiary structure resembles a barrel (Ormδ et al., Science 273 (1996), 1392- 1395 ; Yang, et al., Nature Biotechnol. 14 (1996), 1246-1251). The barrel consists of beta sheets in a compact structure, where, in the center, an alpha helix containing the chromophore is shielded by the barrel. The compact structure makes GFP very stable under diverse and/or harsh conditions such a s protease treatment, making GFP an extremely useful reporter in general. However, the stability of GFP makes it sub-optimal for determining short-term or repetitive events.
A great deal of research is being performed to improve th e properties of GFP and to produce GFP reagents useful and optimized for a variety of research purposes. New versions of GFP have b een developed, such as a "humanized" GFP DNA, the protein product o f which has increased synthesis in mammalian cells (Haas, et al., Current Biology 6 ( 1996), 315-324; Yang, et al., Nucleic Acids Research 24 ( 1996), 4592-4593). One such humanized protein is "enhanced green fluorescent protein" (EGFP). Other mutations to GFP have resulted i n blue-, cyan- and yellow-green light emitting versions. Despite the great utility of GFP, however, other fluorescent proteins with properties similar to or different from GFP would be useful in the art. Novel fluorescent proteins result in possible new colors, or produce pH- dependent fluorescence. Other benefits of novel fluorescent proteins include fluorescence resonance energy transfer (FRET) possibilities based on new spectra and better suitability for larger excitation.
The prior art is deficient in novel fluorescent proteins wherein the DNA coding sequences are known. The present invention fulfills this long-standing need in the art.
SUMMARY OF THE INVENTION
The present invention is directed to DNA sequences encoding fluorescent proteins selected from the group consisting of: (a) an isolated DNA from an organism from the Class Anthozoa which encodes a fluorescent protein; (b) an isolated DNA which hybridizes t o the isolated DNA of (a) and which encodes a fluorescent protein; and (c) an isolated DNA differing from the isolated DNAs of (a) and (b) in codon sequence due to the degeneracy of the genetic code and th at encodes a fluorescent protein. Preferably, the DNA is isolated from a non -bioluminescent organism from Class Anthozoa. More preferably, the DNA has the sequence shown in SEQ ID No. 55 and the fluorescent protein has the amino acid sequence shown in SEQ ID No. 56.
In another embodiment of the present invention, there is provided a vector capable of expressing the DNA of the present invention in a recombinant cell comprising said DNA and regulatory elements necessary for expression of the DNA in the cell. Preferably, the DNA encodes a fluorescent protein having the amino acid sequence shown in SEQ ID No. 56.
In still another embodiment of the present invention, there is provided a host cell transfected with a vector of the present invention, such that the host cell expresses a fluorescent protein . Preferably, the cell is selected from the group consisting of bacterial cells, mammalian cells, plant cells, insect cells and yeast cells. A representative example of bacterial cell is an E. coli cell.
The present invention is also directed to an isolated an d purified fluorescent protein coded for by DNA selected from the group consisting of: (a) isolated DNA from an organism from Class Anthozoa which encodes a fluorescent protein; (b) isolated DNA which hybridizes to the isolated DNA of (a) and which encodes a fluorescent protein; and (c) isolated DNA differing from the isolated DNAs of (a) and (b) in codon sequence due to the degeneracy of the genetic code, and which encodes a fluorescent protein. Preferably, the protein has the amino acid sequence shown in SEQ ID No. 56.
The present invention is also directed to a DNA sequence encoding a fluorescent protein selected from the group consisting of: (a) an isolated DNA which encodes a fluorescent protein, wherein said DNA is from an organism from Class Anthozoa and wherein said organism does not exhibit bioluminescence; (b) an isolated DNA which hybridizes to isolated DNA of (a) and which encodes a fluorescent protein; and (c) an isolated DNA differing from the isolated DNAs o f (a) and (b) in codon sequence due to degeneracy of the genetic co de and which encodes a fluorescent protein. Preferably, the organism is from Sub-class Zoantharia, Order Corallimorpharia. More preferably, the organism is from Family Discosomatidae, Genus Discosoma. Even more preferably, the organism is Discosoma sp. "green ". Most particularly, the present invention is drawn to a novel fluorescent protein from Discosoma sp. "green ", dgFP512.
The present invention is further directed to an amino acid sequence which can be used as a basis for designing an oligonucleotide probe for identification of a DNA encoding a fluorescent protein by means of hybridizaton, wherein the amino acid sequence is selected from the group consisting of SEQ ID Nos. 3, 5, 8, 11, 12, 14. Preferably, such an oligonucleotide has a nucleotide sequence selected from th e group consisting of SEQ ID Nos. 4, 6, 7, 9, 10, 13, 15, 16. Other and further aspects, features, and advantages of th e present invention will be apparent from the following description o f the presently preferred embodiments of the invention given for th e purpose of disclosure.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 shows the modified strategy of 3'-RACE used t o isolate the target fragments. Sequences of the oligonucleotides u s ed are shown in Table 2. Dpi and Dp2 are the degenerate primers used in the first and second PCR, respectively (see Tables 3 and 4 for th e sequences of degenerate primers). In the case of Discosoma sp. "green ", the first degenerate primer used was NGH (SEQ ID No. 4), and the second degenerate primer used was NFP (SEQ ID No. 13) {Please confirm whether the degenerate primers used for dgFP512 are right. If not, please provide the right primers }
Figure 2 shows the excitation and emission spectrum o f the novel fluorescent protein from Discosoma sp. "green ", dgFP512.
DETAILED DESCRIPTION OF THE INVENTION
As used herein, the term "GFP" refers to the basic green fluorescent protein from Aequorea victoria, including prior art versions of GFP engineered to provide greater fluorescence or fluoresce in different colors. The sequence of Aequorea victoria GFP (SEQ ID No.
54) has been disclosed in Prasher et al., Gene 111 (1992), 229-33.
As used herein, the term "EGFP" refers to mutant variant o f GFP having two amino acid substitutions: F64L and S65T (Heim et al., Nature 373 (1995), 663-664). The term "humanized" refers to changes made to the GFP nucleic acid sequence to optimize the codons for expression of the protein in human cells (Yang et al., Nucleic Acids Research 24 (1996), 4592-4593). As used herein, the term "NFP" refers to novel fluorescent protein. Specifically, "NFP" refers to dgFP512 in the present invention.
In accordance with the present invention there may b e employed conventional molecular biology, microbiology, an d recombinant DNA techniques within the skill of the art. Such techniques are explained fully in the literature. See, e.g., Maniatis, Fritsch & Sambrook, "Molecular Cloning: A Laboratory Manual ( 1982) ; "DNA Cloning: A Practical Approach," Volumes l and II (D.N. Glover ed . 1985); "Oligonucleotide Synthesis" (MJ. Gait ed. 1984); "Nucleic Acid Hybridization" (B .D. Hames & S.J. Higgins eds. ( 1985)); "Transcription and Translation" (B.D. Hames & S.J. Higgins eds. ( 1984)); "Animal Cell Culture" (R.I. Freshney, ed. (1986)); "Immobilized Cells and Enzymes" (IRL Press, (1986)); B. Perbal, "A Practical Guide To Molecular Cloning" ( 1 984) . A "vector" is a replicon, such as plasmid, phage or cosmid, to which another DNA segment may be attached so as to bring abou t the replication of the attached segment.
A "DNA molecule" refers to the polymeric form o f deoxyribonucleotides (adenine, guanine, thymine, or cytosine) in either single stranded form or a double-stranded helix. This term refers only to the primary and secondary structure of the molecule, and does no t limit it to any particular tertiary forms. Thus, this term includes double-stranded DNA found, inter alia, in linear DNA molecules (e.g. , restriction fragments), viruses, plasmids, and chromosomes. A DNA "coding sequence" is a DNA sequence which is transcribed and translated into a polypeptide in vivo when placed under the control of appropriate regulatory sequences. The boundaries of the coding sequence are determined by a start codon a t the 5' (amino) terminus and a translation stop codon at the 3 ' (carboxyl) terminus. A coding sequence can include, but is not limited to, prokaryotic sequences, cDNA from eukaryotic mRNA, genomic DNA sequences from eukaryotic (e.g., mammalian) DNA, and synthetic DNA sequences. A polyadenylation signal and transcription termination sequence may be located 3' to the coding sequence. As used herein, the term "hybridization" refers to th e process of association of two nucleic acid strands to form a n antiparallel duplex stabilized by means of hydrogen bonding between residues of the opposite nucleic acid strands. The term "oligonucleotide" refers to a short (under 1 00 bases in length) nucleic acid molecule.
"DNA regulatory sequences", as used herein, are transcriptional and translational control sequences, such as promoters , enhancers, polyadenylation signals, terminators, and the like, th at provide for and/or regulate expression of a coding sequence in a ho s t cell.
A "promoter sequence" is a DNA regulatory region capable of binding RNA polymerase in a cell and initiating transcription of a downstream (3' direction) coding sequence. For purposes of defining the present invention, the promoter sequence is bounded at its 3 ' terminus by the transcription initiation site and extends upstream ( 5 ' direction) to include the minimum number of bases or elements necessary to initiate transcription at levels detectable above background. Within the promoter sequence will be found a transcription initiation site, as well as protein binding domains responsible for the binding of RNA polymerase. Eukaryotic promoters will often, but not always, contain "TATA" boxes and "CAT" boxes . Various promoters, including inducible promoters, may be used t o drive the various vectors of the present invention. As used herein, the terms "restriction endonucleases" an d
"restriction enzymes" refer to bacterial enzymes, each of which c u t double-stranded DNA at or near a specific nucleotide sequence.
A cell has been "transformed" or "transfected" by exogenous or heterologous DNA when such DNA has been introduced inside the cell. The transforming DNA may or may not be integrated (covalently linked) into the genome of the cell. In prokaryotes, yeast, and mammalian cells for example, the transforming DNA may b e maintained on an episomal element such as a plasmid. With respect t o eukaryotic cells, a stably transformed cell is one in which th e transforming DNA has become integrated into a chromosome so that it is inherited by daughter cells through chromosome replication. This stability is demonstrated by the ability of the eukaryotic cell t o establish cell lines or clones comprised of a population of daughter cells containing the transforming DNA. A "clone" is a population o f cells derived from a single cell or common ancestor by mitosis. A "cell line" is a clone of a primary cell that is capable of stable growth in vitro for many generations.
A "heterologous" region of the DNA construct is a n identifiable segment of DNA within a larger DNA molecule that is n o t found in association with the larger molecule in nature. Thus, when the heterologous region encodes a mammalian gene, the gene will usually be flanked by DNA that does not flank the mammalian genomic DNA in the genome of the source organism. In another example, heterologous DNA includes coding sequence in a construct where portions of genes from two different sources have been brought together so as to produce a fusion protein product. Allelic variations or naturally-occurring mutational events do not give rise to a heterologous region of DNA as defined herein. As used herein, the term "reporter gene" refers to a coding sequence attached to heterologous promoter or enhancer elements an d whose product may be assayed easily and quantifiably when th e construct is introduced into tissues or cells. The amino acids described herein are preferred to be in th e "L" isomeric form. The amino acid sequences are given in one-letter code (A: alanine; C: cysteine; D: aspartic acid; E: gluetamic acid; F: phenylalanine; G: glycine; H: histidine; I: isoleucine; K: lysine; L: leucine; M: metionine; N: asparagine; P: proline; Q: gluetamine; R: arginine; S: serine; T: threonine; V: valine; W: tryptophane; Y: tyrosine; X: any residue). NH2 refers to the free amino group present at the amino terminus of a polypeptide. COOH refers to the free carboxy group present at the carboxy terminus of a polypeptide. In keeping with standard polypeptide nomenclature, J Biol. Chem., 243 (1969), 3552- 59 is used.
The present invention is directed to an isolated DNA selected from the group consisting of: (a) isolated DNA from a n organism from the Class Anthozoa which encodes a fluorescent protein; (b) isolated DNA which hybridizes to isolated DNA of (a) an d which encodes a fluorescent protein; and (c) isolated DNA differing from the isolated DNAs of (a) and (b) in codon sequence due to th e degeneracy of the genetic code, and which encodes a fluorescent protein. Preferably, the DNA has the sequence shown in SEQ ID No. 5 5 and the fluorescent protein has the amino acid sequence shown in SEQ ID No. 56.
In another embodiment of the present invention, there is provided a vector capable of expressing the DNA of the present invention in a recombinant cell comprising said DNA and regulatory elements necessary for expression of the DNA in the cell. Specifically, the DNA encodes a fluorescent protein having the amino acid sequence shown in SEQ ID No. 56.
In still another embodiment of the present invention, there is provided a host cell transfected with the vector of the present invention, which expresses a fluorescent protein of the present invention. Preferably, the cell is selected from the group consisting o f bacterial cells, mammalian cells, plant cells, insect cells and yeast cells. A representative example of bacterial cell is an E. coli cell. The present invention is also directed to a DNA sequence encoding a fluorescent protein selected from the group consisting of: (a) an isolated DNA which encodes a fluorescent protein, wherein said DNA is from an organism from Class Anthozoa and wherein said organism does not exhibit bioluminescence; (b) an isolated DNA which hybridizes to isolated DNA of (a) and which encodes a fluorescent protein; and (c) an isolated DNA differing from the isolated DNAs o f
(a) and (b) in codon sequence due to degeneracy of the genetic c o de and which encodes a fluorescent protein. Preferably, the organism is from Sub-class Zoantharia, Order Corallimorpharia. More preferably, the organism is from Family Discosomatidae, Genus Discosoma. Most preferably, the organism is Discosoma sp. "green ".
The present invention is also directed to an isolated and purified fluorescent protein coded for by DNA selected from the group consisting of: (a) an isolated protein encoded by a DNA which encodes a fluorescent protein wherein said DNA is from an organism from Class
Anthozoa and wherein said organism does not exhibit bioluminescence ;
(b) an isolated protein encoded by a DNA which hybridizes to isolated DNA of (a); and (c) an isolated protein encoded by a DNA differing from the isolated DNAs of (a) and (b) in codon sequence due t o degeneracy of the genetic code. Preferably, the isolated and purified fluorescent protein is dgFP512.
The present invention is further directed to an amino acid sequence which can be used as a basis for designing an oligonucleotide probe for identification of a DNA encoding a fluorescent protein by means of hybridizaton, wherein the amino acid sequence is selected from the group consisting of SEQ ID Nos. 3, 5, 8, 11, 12, 14. Preferably, such an oligonucleotide has a nucleotide sequence selected from th e group consisting of SEQ ID Nos. 4, 6, 7, 9, 10, 13, 15, 16 and is used a s a primer in polymerase chain reaction. Alternatively, it can be used a s a probe for hybridization screening of the cloned genomic or cDNA library.
The following examples are given for the purpose o f illustrating various embodiments of the invention and are not meant t o limit the present invention in any fashion.
EXAMPLE 1
Rio ical Material Novel fluorescent proteins were identified from several genera of Anthozoa which do not exhibit any bioluminescence but have fluorescent color as observed under usual white light or ultraviolet light. Six species were chosen (see Table 1).
TABLE 1
Anthozoa Species Used in This Study
Species Area of Origination Fluorescent Color
Anemonia Western Pacific bright green tentacle tips maj ano
Clavularia sp. Western Pacific bright green tentacles and oral disk
Zoanthus sp. Western Pacific green-yellow tentacles and oral disk
Discosoma sp . Western Pacific orange-red spots oral disk "red"
Discosoma Western Pacific blue-green stripes on oral striata disk
Discosoma sp . Western Pacific faintly purple oral disk "magenta"
Discosoma sp . Western Pacific green spots on oral disk "green"
Anemonia Mediterranean purple tentacle tips sulcata
EXAMPLE 2
cDN Preparation
Total RNA was isolated from the species of interest according to the protocol of Chomczynski and Sacchi (Chomczynski P., et al., Anal. Biochem. 162 (1987), 156- 159). First-strand cDNA was synthetized starting with 1-3 μg of total RNA using SMART PCR cDNA synthesis kit (CLONTECH) according to the provided protocol with th e only alteration being that the "cDNA synthesis primer" provided in th e kit was replaced by the primer TN3 (5'- CGCAGTCGACCG(T)13, SEQ ID No. 1) (Table 2). Amplified cDNA samples were then prepared a s described in the protocol provided except the two primers used for PCR were the TS primer (5'-AAGCAGTGGTATCAACGCAGAGT, SEQ ID No. 2 ) (Table 2) and the TN3 primer (Table 2), both in 0.1 μM concentration. Twenty to twenty-five PCR cycles were performed to amplify a cDNA sample. The amplified cDNA was diluted 20-fold in water and 1 μl o f this dilution was used in subsequent procedures.
TABLE 2
ligns Used in r.DNA Synthesis and R AGF.
TN3: 5'-CGCAGTCGACCG(T)]3
(SEQ ID No. 1)
T7-TN3 : 5'-GTAATACGACTCACTATAGGGCCGCAGTCGACCG(T)13
(SEQ ID No. 17)
TS -primer : 5'-AAGCAGTGGTATCAACGCAGAGT
(SEQ ID No. 2)
T7-TS: 5'-GTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT
(SEQ ID No. 18)
T7 : 5'-GTAATACGACTCACTATAGGGC
(SEQ ID No. 19)
T S - oligo 5 ' -AAGC AGTGGTATCAACGCAGAGTACGCrGrGrG
(SEQ ID No. 53)
EXAMPLE 3
Olign Design
To isolate fragments of novel fluorescent protein cDNAs, PCR using degenerate primers was performed. Degenerate primers were designed to match the sequence of the mRNAs in regions that were predicted to be the most invariant in the family of fluorescent proteins. Four such stretches were chosen (Table 3) and variants o f degenerate primers were designed. All such primers were directed t o the 3 '-end of mRNA. All oligos were gel-purified before use. Table 2 shows the oligos used in cDNA synthesis and RACE.
TABLE 3
Key Amino Acid Stretches and Corresponding Degenerate Primers Used for Isolation of Fluorescent Proteins
Figure imgf000019_0001
EXAMPLE 4
Isolation of 3'-cDNA Fragments of nFPs
The modified strategy of 3'-RACE was used to isolate th e target fragments (see Figure 1). The RACE strategy involved two consecutive PCR steps. The first PCR step involved a first degenerate primer (Table 4) and the T7-TN3 primer (SEQ ID No. 17) which has a 3 ' portion identical to the TN3 primer used for cDNA synthesis (for sequence of T7-TN3, Table 2). The reason for substituting the longer T7-TN3 primer in this PCR step was that background amplification which occurred when using the shorter TN3 primer was suppres sed effectively, particularly when the T7-TN3 primer was used at a low concentration (0.1 _M) (Frohman et al., (1998) PNAS USA, 85, 8998 - 9002). The second PCR step involved the TN3 primer (SEQ ID No. 1 , Table 2) and a second degenerate primer (Table 4).
TABLE 4
Combinations of Degenerate Primers for First and Second PCR Resulting in Specific Amplification of 3 '-Fragments of nFP cDNA
Species First Second Degenerate Primer
Degenerate
Primer
Anemonia majano NGH GNGb
(SEQ ID No. 4) (SEQ ID No. 10)
Clavularia sp. NGH GEGa
(SEQ ID No. 4) (SEQ ID No. 6)
Zoanthus sp. NGH GEGa
(SEQ ID No. 4) (SEQ ID No. 6)
Discosoma sp. "red" NGH GEGa (SEQ ID No. 6), (SEQ ID No. 4) NFP (SEQ ID No. 13) or PVMb (SEQ ID No. 16)
Discosoma striata NGH NFP (SEQ ID No. 4) (SEQ ID No. 13)
Anemonia sulcata NGH GEGa (SEQ ID No. 6)
(SEQ ID No. 4) or NFP (SEQ ID No. 13)
The first PCR reaction was performed as follows: 1 μl of 20-fold dilution of the amplified cDNA sample was added into the reaction mixture containing IX Advantage KlenTaq Polymerase Mix with provided buffer (CLONTECH), 200 μM dNTPs, 0.3 μM of first degenerate primer (Table 4) and 0.1 μM of T7-TN3 (SEQ ID No. 17) primer in a total volume of 20 μl. The cycling profile was (Hybaid OmniGene Thermocycler, tube control mode): 1 cycle for 95°C, 10 sec; 55°C, 1 min.; 72°C, 40 sec; 24 cycles for 95°C, 10 sec; 62°C, 30 sec; 72°C, 4 0 sec. The reaction was then diluted 20-fold in water and 1 μl of this dilution was added to a second PCR reaction, which contained IX Advantage KlenTaq Polymerase Mix with the buffer provided by th e manufacturer (CLONTECH), 200 μM dNTPs, 0.3 μM of the s econd degenerate primer (Table 4) and 0.1 μM of TN3 primer. The cycling profile was (Hybaid OmniGene Thermocycler, tube control mode): 1 cycle for 95°C, 10 sec; 55°C (for GEG/GNG or PVM) or 52°C (for NFP), 1 min.; 72°C, 40 sec; 13 cycles for 95°C, lOsec; 62°C (for GEG/GNG o r PVM) or 58°C (for NFP), 30 sec; 72°C, 40 sec. The product of PCR was cloned into PCR-Script vector (Stratagene) according to th e manufacturer' s protocol.
Different combinations of degenerate primers were tried in the first and second PCR reactions on the DNA from each species until a combination of primers was found that resulted in specific amplification—meaning that a pronounced band of expected size (about 650-800 bp for NGH and GEG/GNG and 350-500 bp for NFP and PVM— sometimes accompanied by a few minor bands) was detected o n agarose gel after two PCR reactions. The primer combinations o f choice for different species of the Class Anthozoa are listed in Table 4. Some other primer combinations also resulted in amplification o f fragments of correct size, but the sequence of these fragments showed no homology to the other fluorescent proteins identified or t o Aequorea victoria GFP. EXAMPLE 5
Obtaining Full- ength cDNA Copies
Upon sequencing the obtained 3 '-fragments of novel fluorescent protein cDNAs, two nested 5 '-directed primers were synthesized for cDNA (Table 5), and the 5' ends of the cDNAs were then amplified using two consecutive PCRs. In the next PCR reaction, the novel approach of "step-out PCR" was used to suppress background amplification. The step-out reaction mixture contained lx Advantage KlenTaq Polymerase Mix using buffer provided by the manufacturer (CLONTECH), 200 μM dNTPs, 0.2 μM of the first gene-specific primer (see Table 5), 0.02 μM of the T7-TS primer (SEQ ID No. 18), 0.1 μM o f T7 primer (SEQ ID No. 19) and 1 μl of the 20-fold dilution of th e amplified cDNA sample in a total volume of 20 μl. The cycling profile was (Hybaid OmniGene Thermocycler, tube control mode): 23 - 27 cycles for 95°C, 10 sec; 60°C, 30 sec; 72°C, 40 sec. The product of amplification was diluted 50-fold in water and one μl of this dilution was added to the second (nested) PCR. The reaction contained IX Advantage KlenTaq Polymerase Mix with provided buffer (CLONTECH), 200 μM dNTPs, 0.2 μM of the second gene-specific primer and 0.1 μM of TS primer (SEQ ID No. 2) in a total volume of 20 μl. The cycling profile was (Hybaid OmniGene Thermocycler, tube control mode): 1 2 cycles for 95°C, 10 sec; 60°C, 30 sec; 72°C, 40 sec. The product o f amplification was then cloned into p Atlas vector (CLONTECH) according to the manufacturer' s protocol. TABLE
Gene-Specific Primers Used for 5'-R ACF.
Species First Primer Second (Nested) Primer
Anemonia 5 '-GAAATAGTCAGGCATACTGGT 5'-GTCAGGCATAC maj ano (SEQ ID No. 20) TGGTAGGAT (SEQ ID No. 21)
Clavularia 5 '-CTTGAAATAGTCTGCTATATC 5'-TCTGCTATATC sp . (SEQ ID No. 22) GTCTGGGT (SEQ ID No. 23)
Zoanthus 5 ' - 5 '-GTCTACTATGTCTT sp . GTTCTTGAAATAGTCTACTATGT GAGGAT
(SEQ ID No. 24) (SEQ ID No. 25)
Discosoma 5'-CAAGCAAATGGCAAAGGTC 5'-CGGTATTGTGGCC sp. "red" (SEQ ID No. 26) TTCGTA (SEQ ID No. 27)
Discosoma 5 ' -TTGTCTTCTTCTGC AC AAC 5'-CTGCACAACGG striata (SEQ ID No. 28) GTCCAT (SEQ ID No. 29)
Anemonia 5'-CCTCTATCTTCATTTCCTGC 5'-TATCTTCATTTCCT sulcata (SEQ ID No. 30) GCGTAC (SEQ ID No. 31)
Discosoma 5'-TTCAGCACCCCATCACGAG 5'-ACGCTCAGAGCTG sp . (SEQ ID No. 32) GGTTCC
"magenta" (SEQ ID No. 33)
Discosoma 5'-CCCTCAGCAATCCATCACGTTC 5'-ATTATCTCAGTGGA sp. "green" (SEQ ID No. 34) TGGTTC (SEQ ID No. 35) EXAMPLE S
Expression of nFP in E. r.ol.i To prepare a DNA construct for novel fluorescent protein expression, two primers were synthesized for each cDNA: a 5 ' -directed "downstream" primer with the annealing site located in the 3'-UTR o f the cDNA and a 3 '-directed "upstream" primer corresponding to th e site of translation start site (not including the first ATG codon) (Table 6). Primers with SEQ ID Nos. 51 and 52 were the primers used t o prepare the dgFP512 DNA. Both primers had 5'-heels coding for a site for a restriction endonuclease; in addition, the upstream primer was designed so as to allow the cloning of the PCR product into the pQE30 vector (Qiagen) in such a way that resulted in the fusion of reading frames of the vector-encoded 6xHis-tag and nFP. The PCR was performed as follows: 1 μl of the 20-fold dilution of the amplified cDNA sample was added to a mixture containing lx Advantage KlenTaq Polymerase Mix with buffer provided by the manufacturer (CLONTECH), 200 μM dNTPs, 0.2 μM of upstream primer and 0.2 μM of downstream primer, in a final total volume of 20 μl. The cycling profile was (Hybaid OmniGene Thermocycler, tube control mode): 23-27 cycles for 95°C , 10 sec; 60°C, 30 sec; 72°C, 40 sec. The product of this amplification step was purified by phenol-chlorophorm extraction and ethanol precipitation and then cloned into pQE30 vector using restriction endonucleases corresponding to the primers' sequence according t o standard protocols.
All plasmids were amplified in XL-1 blue E. coli and purified by plasmid DNA miniprep kits (CLONTECH). The recombinant clones were selected by colony color, and grown in 3 ml of LB medium (supplemented with 100 μg/ml of ampicillin) at 37°C overnight. 100 μl of the overnight culture was transferred into 200 ml of fresh LB medium containing 100 μg/ml of ampicillin and grown at 37°C, 200 rpm up to OD600 0.6-0.7. 1 mM IPTG was then added to the culture an d incubation was allowed to proceed at 37°C for another 16 hours. The cells were harvested and recombinant protein, which incorporated 6 x His tags on the N-terminus, was purified using TALON™ metal-affinity resin according to the manufacturer's protocol (CLONTECH).
TABLE 6
Primers Used to Obtain Full Coding Region of nFPs for Cloning into
Expression Construct
Species Upstream Primer Downstream Primer
Anemonia 5' -acatggatccgctctttcaaaca 5'-tagtactcgagcttattcgta majano agtttatc (SEQ ID No.36) tttcagtgaaatc BamHI (SEQ ID No.37) Xhol
5 ' -acatggatccaacatttttttga gaaacg (SEQ ID No.38) 5'-tagtactc a caacacaa
Clavularia BamHI accctcagacaa sp. 5'-acatggatccaaagctctaacc (SEQ ID No.40) accatg (SEQ ID No.39) Xhol BamHI
Zoanthus 5'- acatggatccgctcagtcaaag 5'-tagtactcgaggttggaactacat sp. cacggt (SEQ ID No.41) tcttatca (SEQ ID No.42) BamHI Xhol
Discosoma 5'- ac. .caggtcttccaagaat 5 ' -tagta£j_c_g-aggagccaagttc sp. "red" gttatc (SEQ ID No.43) agcctta (SEQ ID No.44) BamHI Xhol
Discosoma 5'- acat.ggatccagttggtccaagagtgtg 5'-tagc.gjςLgc_Lctatcatgcctc striata (SEQ ID No.45) gtcacct (SEQ ID No.46)
BamHI Sacl
Anemonia 5'- acaJ-ggϋlccgcttcctttttaaagaagact 5'-tagtactcgagtccttgggagc sulcata (SEQ ID No.47) ggcttg (SEQ ID No.48) BamHI Xhol
Discosoma 5'- cagttgttccaagaatgtgat -tagtac_tiig_aggccattacg sp. (SEQ ID No.49) ctaatc (SEQ ID No.50)
"magenta" BamHI Xhol
Discosoma 5'-ac t g tcc gtgcacttaaagaagaaatj 5'-tagtactcgagattcggtttaat sp. "green" (SEQ ID No.51) gccttg (SEQ ID No.52) EXAMPLE 7
Novel Fluorescent Proteins and cDNAs Encoding the Proteins
One of the full-length cDNAs encoding fluorescent proteins found is described herein (dgFP512). The nucleic acid sequence an d deduced amino acid sequence are SEQ ID Nos. 55 and 56, respectively. The spectral properties of dgFP512 is listed in Table 7, and the emission and excitation spectra for the dgFP512 is shown in Figure 2.
TABLE 7
** L- I
Species : Discosoma sp. Max. Extinction
"green" Coefficient: 20, 360 nFP Name: dgFP512 Quantum Yield 0.24
Absorbance Relative
Max. (nm): 502 Brightness: * 0.21
Emission
Max. (nm): 5 1 2
*relative brightness is extinction coefficient multiplied by qu antum yield divided by the same value for A. victoria GFP .
Any patents or publications mentioned in this specification are indicative of the levels of those skilled in the art to which th e invention pertains. These patents and publications are incorporated b y reference to the same extent as if each individual publication was specifically and individually indicated to be incorporated by reference. One skilled in the art will appreciate readily that the present invention is adapted to carry out the objects and obtain the ends an d advantages mentioned, as well as those objects and ends inherent therein. The present examples, along with the methods, procedures , treatments, molecules, and specific compounds described herein, ar e presently representative of preferred embodiments, are exemplary, an d are not intended as limitations on the scope of the invention. Changes to the methods and compounds, and other uses, will occur to tho s e skilled in the art and are encompassed within the spirit of the invention as defined by the scope of the claims.

Claims

WHAT IS CLAIMED IS:
1 . A DNA sequence encoding a fluorescent protein selected from the group consisting of: ( a ) an isolated DNA which encodes a fluorescent protein, wherein said DNA is from an organism from a Class Anthozoa an d wherein said organism does not exhibit bioluminescence;
( b ) an isolated DNA which hybridizes to isolated DNA o f (a) above and which encodes a fluorescent protein; and ( c ) an isolated DNA differing from the isolated DNAs of
(a) and (b) above in codon sequence due to degeneracy of the genetic code and which encodes a fluorescent protein.
2 . The DNA sequence of claim 1, wherein said organism is from Sub-class Zoantharia.
3 . The DNA sequence of claim 2, wherein said organism is from Order Corallimorpharia.
4 . The DNA sequence of claim 3, wherein said organism is from Family Discosomatidae.
5 . The DNA sequence of claim 4, wherein said organism is from Genus Discosoma.
6. The DNA sequence of claim 5, wherein said organism is Discosoma sp. "green ".
7 . A DNA sequence encoding a fluorescent protein selected from the group consisting of:
( a ) an isolated DNA which encodes a fluorescent protein having a nucleotide sequence shown in SEQ ID No. 55;
( b ) an isolated DNA which hybridizes to isolated DNA o f (a) above and which encodes a fluorescent protein; and
( c ) an isolated DNA differing from the isolated DNAs o f (a) and (b) above in codon sequence due to degeneracy of the genetic code, and which encodes a fluorescent protein.
8 . The DNA of claim 7, wherein said DNA encodes a fluorescent protein having an amino acid sequence shown in SEQ ID No. 56.
9 . A vector capable of expressing the DNA of claim 1 in a recombinant cell, said vector comprising said DNA of claim 1 an d regulatory elements necessary for expression of the DNA in the cell.
1 0. The vector of claim 9, wherein said DNA encodes a fluorescent protein having the amino acid sequence shown in SEQ ID
No. 56.
1 1 . A host cell transfected with the vector of claim 9 , wherein said cell is capable of expressing a fluorescent protein.
1 2. The host cell of claim 11 , wherein said cell is selected from the group consisting of bacterial cells, mammalian cells, plant cell, yeast and insect cells.
1 3 . The host cell of claim 12, wherein said bacterial cell is an E. coli cell.
1 4. An isolated and purified fluorescent protein coded for by DNA selected from the group consisting of:
( a ) an isolated DNA which encodes a fluorescent protein from an organism from Class Anthozoa, wherein said organism doe s not exhibit bioluminescence;
( b ) an isolated DNA which hybridizes to isolated DNA o f (a) above and which encodes a fluorescent protein; and
( c ) an isolated DNA differing from the isolated DNAs o f (a) and (b) above in codon sequence due to degeneracy of the genetic code and which encodes a fluorescent protein.
1 5. The isolated and purified fluorescent protein of claim
14, wherein said organism is from Sub-class Zoantharia.
1 6. The isolated and purified fluorescent protein of claim
15, wherein said organism is from Order Corallimorpharia.
1 7. The isolated and purified fluorescent protein of claim
16, wherein said organism is from Family Discosomatidae.
1 8. The isolated and purified fluorescent protein of claim 17, wherein said organism is from Genus Discosoma.
1 9. The isolated and purified fluorescent protein of claim 18, wherein said organism is Discosoma sp. "green ".
20. An isolated and purified fluorescent protein coded for by DNA selected from the group consisting of:
( a ) isolated DNA which encodes a fluorescent protein having an amino acid sequence shown in SEQ ID No. 56;
( b ) isolated DNA which hybridizes to isolated DNA of ( a ) above and which encodes a fluorescent protein; and
( c ) isolated DNA differing from said isolated DNAs of ( a ) and (b) above in codon sequence due to degeneracy of the genetic code and which encodes a fluorescent protein.
2 1 . The isolated and purifed fluorescent protein of claim 20, wherein said protein is dgFP512.
22. An amino acid sequence which can be used as a basis for designing an oligonucleotide probe for identification of a DNA encoding a fluorescent protein by means of hybridizaton, wherein said sequence is selected from the group consisting of SEQ ID Nos. 3, 5, 8 ,
11 , 12, 14.
23 . The amino acid sequence of claim 22, wherein said oligonucleotide has a nucleotide sequence selected from the group consisting of SEQ ID Nos. 4, 6, 7, 9, 10, 13, 15, 16
PCT/US1999/029404 1998-12-11 1999-12-10 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof WO2000034323A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21033098A 1998-12-11 1998-12-11
US09/210,330 1998-12-11
US44433899A 1999-11-19 1999-11-19
US09/444,338 1999-11-19

Publications (1)

Publication Number Publication Date
WO2000034323A1 true WO2000034323A1 (en) 2000-06-15

Family

ID=26905062

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/029404 WO2000034323A1 (en) 1998-12-11 1999-12-10 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof

Country Status (1)

Country Link
WO (1) WO2000034323A1 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1135532A1 (en) * 1998-12-11 2001-09-26 Clontech Laboratories Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
JP2003527833A (en) * 1999-10-14 2003-09-24 クロンテック・ラボラトリーズ・インコーポレーテッド Chromophores / phosphors derived from flower insects and their use
EP1540008A2 (en) * 2002-07-19 2005-06-15 Diversa Corporation Fluorescent proteins, nucleic acids encoding them and methods for making and using them
US6969597B2 (en) 2001-02-21 2005-11-29 Clontech Laboratories, Inc. Nucleic acids encoding non aggregating fluorescent proteins and methods for using the same
US6977293B1 (en) 2000-11-03 2005-12-20 Ceres, Inc. Chimeric polypeptides
US7157565B2 (en) 2000-10-12 2007-01-02 Clontech Laboratories, Inc. Far red shifted fluorescent proteins
US7183399B2 (en) 2001-10-12 2007-02-27 Clontech Laboratories, Inc. Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
WO2007059077A2 (en) 2005-11-14 2007-05-24 E.I.Du Pont De Nemours And Company Compositions and methods for altering alpha- and beta-tocotrienol content
US7338785B2 (en) 1998-12-11 2008-03-04 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US7479555B2 (en) 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
US7485715B2 (en) 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
US7537915B2 (en) 1998-12-11 2009-05-26 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
DE102010018878A1 (en) 2009-04-30 2010-11-04 Julius-Maximilians-Universität Würzburg New cell line stably expressing both beta-adrenergic receptor and a cyclic adenosine monophosphate sensor, useful for diagnosing beta-adrenergic receptor-mediated disease including e.g. infectious and non-infectious heart diseases
EP2284195A1 (en) 2001-09-18 2011-02-16 Carnegie Institution Of Washington Fusion proteins useful for detecting analytes
US9758790B2 (en) 2004-12-08 2017-09-12 Ceres, Inc. Modulating the level of components within plants
US9834584B2 (en) 1998-12-11 2017-12-05 Takara Bio Usa, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718640A1 (en) * 1997-05-02 1999-07-22 Joerg Wiedenmann Protein derived from Anemonia useful in gene technology and molecular biology

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19718640A1 (en) * 1997-05-02 1999-07-22 Joerg Wiedenmann Protein derived from Anemonia useful in gene technology and molecular biology

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDERLUH ET AL.: "Cloning, sequencing and expression of equinatoxin II", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 220, no. 2, 1996, pages 437 - 442, XP002925476 *
MACEK ET AL.: "Intrinsic tryptophan fluorescence of equinatoxin II, a pore-forming polypeptide from the sea anemone, Actinia equina L, monitors its interaction with lipid membranes", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 234, 1995, pages 329 - 335, XP002925477 *
MATZ ET AL.: "Fluorescent proteins from nonbioluminescent Anthozoa species", NATURE BIOTECHNOLOGY, vol. 17, no. 10, October 1999 (1999-10-01), pages 969 - 973, XP000882891 *

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7537915B2 (en) 1998-12-11 2009-05-26 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US7442521B2 (en) 1998-12-11 2008-10-28 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US7338782B2 (en) 1998-12-11 2008-03-04 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US7338783B2 (en) 1998-12-11 2008-03-04 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US8012682B2 (en) 1998-12-11 2011-09-06 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
EP1135532A1 (en) * 1998-12-11 2001-09-26 Clontech Laboratories Inc. Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
EP1135532A4 (en) * 1998-12-11 2004-11-03 Clontech Lab Inc Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
US9834584B2 (en) 1998-12-11 2017-12-05 Takara Bio Usa, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US7338784B2 (en) 1998-12-11 2008-03-04 Clontech Laboratories, Inc Nucleic acids encoding chromophores/fluorophores and methods for using the same
US7338785B2 (en) 1998-12-11 2008-03-04 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US7344862B2 (en) 1998-12-11 2008-03-18 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
US7442522B2 (en) 1998-12-11 2008-10-28 Clontech Laboratories, Inc. Nucleic acids encoding chromo or fluorescent proteins and method for using the same
US7485715B2 (en) 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
US7479555B2 (en) 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
US7166444B2 (en) 1999-10-14 2007-01-23 Clontech Laboratories, Inc. Nucleic acids encoding chromophores/fluorophores and methods for using the same
JP2003527833A (en) * 1999-10-14 2003-09-24 クロンテック・ラボラトリーズ・インコーポレーテッド Chromophores / phosphors derived from flower insects and their use
US7157565B2 (en) 2000-10-12 2007-01-02 Clontech Laboratories, Inc. Far red shifted fluorescent proteins
US6977293B1 (en) 2000-11-03 2005-12-20 Ceres, Inc. Chimeric polypeptides
US8093450B2 (en) 2001-02-21 2012-01-10 Clontech Laboratories, Inc. Non-aggregating fluorescent proteins and methods for using the same
US7150979B2 (en) 2001-02-21 2006-12-19 Clontech Laboratories, Inc. Nucleic acids encoding non-aggregating fluorescent proteins and methods for using the same
US7858844B2 (en) 2001-02-21 2010-12-28 Clontech Laboratories, Inc. Non aggregating fluorescent proteins and methods for using the same
US6969597B2 (en) 2001-02-21 2005-11-29 Clontech Laboratories, Inc. Nucleic acids encoding non aggregating fluorescent proteins and methods for using the same
US8431769B2 (en) 2001-02-21 2013-04-30 Clontech Laboratories, Inc. Non-aggregating fluorescent proteins and methods for using the same
EP2284195A1 (en) 2001-09-18 2011-02-16 Carnegie Institution Of Washington Fusion proteins useful for detecting analytes
US7183399B2 (en) 2001-10-12 2007-02-27 Clontech Laboratories, Inc. Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
EP1540008A4 (en) * 2002-07-19 2006-04-12 Diversa Corp Fluorescent proteins, nucleic acids encoding them and methods for making and using them
EP1540008A2 (en) * 2002-07-19 2005-06-15 Diversa Corporation Fluorescent proteins, nucleic acids encoding them and methods for making and using them
US9758790B2 (en) 2004-12-08 2017-09-12 Ceres, Inc. Modulating the level of components within plants
WO2007059077A2 (en) 2005-11-14 2007-05-24 E.I.Du Pont De Nemours And Company Compositions and methods for altering alpha- and beta-tocotrienol content
DE102010018878A1 (en) 2009-04-30 2010-11-04 Julius-Maximilians-Universität Würzburg New cell line stably expressing both beta-adrenergic receptor and a cyclic adenosine monophosphate sensor, useful for diagnosing beta-adrenergic receptor-mediated disease including e.g. infectious and non-infectious heart diseases

Similar Documents

Publication Publication Date Title
EP1135532B1 (en) Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034318A1 (en) Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034326A1 (en) Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
AU783767B2 (en) Anthozoa derived chromophores/fluorophores and methods for using the same
WO2000034321A1 (en) Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034323A1 (en) Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034322A1 (en) Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
WO2000034324A1 (en) Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
RU2303600C2 (en) New chromophores/fluorophores and uses thereof
US7157565B2 (en) Far red shifted fluorescent proteins
AU2003208520B2 (en) Fluorescent protein from aequorea coerulscens and uses therof
AU2002211722A1 (en) Nucleic acids encoding stichodactylidae chromoproteins
US7358336B2 (en) Fluorescent protein from Montastraea cavernosa
AU2003208520A1 (en) Fluorescent protein from aequorea coerulscens and uses therof
CA2467383C (en) Rapidly maturing fluorescent proteins and methods for using the same
US7067645B2 (en) mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof
AU2002361624A1 (en) Novel chromophores/fluorophores and methods for using the same
AU2006200881A1 (en) Anthozoa derived chromophores/fluorophores and methods for using the same
NZ517548A (en) Non-bioluminescent Anthozoa derived chromophores / fluorophores and methods for using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase